» Articles » PMID: 22253564

TGFβ Signaling and Cardiovascular Diseases

Overview
Journal Int J Biol Sci
Specialty Biology
Date 2012 Jan 19
PMID 22253564
Citations 84
Authors
Affiliations
Soon will be listed here.
Abstract

Transforming growth factor β (TGFβ) family members are involved in a wide range of diverse functions and play key roles in embryogenesis, development and tissue homeostasis. Perturbation of TGFβ signaling may lead to vascular and other diseases. In vitro studies have provided evidence that TGFβ family members have a wide range of diverse effects on vascular cells, which are highly dependent on cellular context. Consistent with these observations genetic studies in mice and humans showed that TGFβ family members have ambiguous effects on the function of the cardiovascular system. In this review we discuss the recent advances on TGFβ signaling in (cardio)vascular diseases, and describe the value of TGFβ signaling as both a disease marker and therapeutic target for (cardio)vascular diseases.

Citing Articles

Exploring Bone Morphogenetic Protein-2 and -4 mRNA Expression and Their Receptor Assessment in a Dynamic Model of Vascular Calcification.

Cabiati M, Vozzi F, Ceccherini E, Guiducci L, Persiani E, Gisone I Cells. 2025; 13(24.

PMID: 39768183 PMC: 11674890. DOI: 10.3390/cells13242091.


A multi-omics approach identifies the key role of disorders of sphingolipid metabolism in Ang II-induced hypertensive cardiomyopathy myocardial remodeling.

Qu Y, Ma D, Wu T, Wang H, Tian Z, Liu X Sci Rep. 2024; 14(1):30379.

PMID: 39638825 PMC: 11621778. DOI: 10.1038/s41598-024-81611-8.


Potential effects of a human milk oligosaccharide 6'-sialyllactose on angiotensin II-induced aortic aneurysm via p90RSK/TGF-β/SMAD2 signaling pathway.

Nguyen T, Nguyen D, Jin Y, Kim L, Heo K Arch Pharm Res. 2024; 47(10-11):854-869.

PMID: 39463210 DOI: 10.1007/s12272-024-01515-z.


EVs-miR-17-5p attenuates the osteogenic differentiation of vascular smooth muscle cells potentially via inhibition of TGF-β signaling under high glucose conditions.

Baba I, Matoba T, Katsuki S, Koga J, Kawahara T, Kimura M Sci Rep. 2024; 14(1):16323.

PMID: 39009669 PMC: 11251274. DOI: 10.1038/s41598-024-67006-9.


Endothelial-to-Mesenchymal Transition in Cardiovascular Pathophysiology.

Singh A, Bhatt K, Nguyen H, Frisbee J, Singh K Int J Mol Sci. 2024; 25(11).

PMID: 38892367 PMC: 11173124. DOI: 10.3390/ijms25116180.


References
1.
Jerkic M, Kabir M, Davies A, Yu L, McIntyre B, Husain N . Pulmonary hypertension in adult Alk1 heterozygous mice due to oxidative stress. Cardiovasc Res. 2011; 92(3):375-84. DOI: 10.1093/cvr/cvr232. View

2.
Loeys B, Schwarze U, Holm T, Callewaert B, Thomas G, Pannu H . Aneurysm syndromes caused by mutations in the TGF-beta receptor. N Engl J Med. 2006; 355(8):788-98. DOI: 10.1056/NEJMoa055695. View

3.
Deaton R, Su C, Valencia T, Grant S . Transforming growth factor-beta1-induced expression of smooth muscle marker genes involves activation of PKN and p38 MAPK. J Biol Chem. 2005; 280(35):31172-81. DOI: 10.1074/jbc.M504774200. View

4.
Watabe T, Nishihara A, Mishima K, Yamashita J, Shimizu K, Miyazawa K . TGF-beta receptor kinase inhibitor enhances growth and integrity of embryonic stem cell-derived endothelial cells. J Cell Biol. 2003; 163(6):1303-11. PMC: 2173713. DOI: 10.1083/jcb.200305147. View

5.
Lebrin F, Srun S, Raymond K, Martin S, van den Brink S, Freitas C . Thalidomide stimulates vessel maturation and reduces epistaxis in individuals with hereditary hemorrhagic telangiectasia. Nat Med. 2010; 16(4):420-8. DOI: 10.1038/nm.2131. View